{"Azathioprine can be affected by a patient's TPMT and NUDT15 phenotype. This patient is predicted to be a NUDT15 poor metabolizer and is at high risk for life threatening myelosuppression with normal doses of azathioprine. Consider alternative non-thiopurine immunosuppressant therapy. Please consult a clinical pharmacist for more information."}